Research on HIV/AIDS Drug Resistance
Overviews
 This Week in HIV Research: Exorcizing Our PrEP Demons (March 21, 2019)
From TheBodyPRO
 Two Generations Explore HIV Drug Resistance in Trans Women, MSM (March 20, 2019)
From TheBodyPRO
 ART Resistance Spreads: A Top HIV Clinical Development of 2017 (November 15, 2017)
From TheBodyPRO
 Ibalizumab: First Long-Acting HIV Treatment Available Now Via Expanded Access (May 16, 2017)
From TheBody
 Pre-ART Drug Resistance in Rural South Africa but Limited Clinical Impact With Good Adherence (April 2017)
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
 Assessing Benefits of Pre-Exposure Prophylaxis Relative to Risks of Drug Resistance (September 14, 2016)
In The 21st International AIDS Conference (AIDS 2016), from TheBodyPRO
 New HIV Resistance to Antiretrovirals Almost Disappears in Switzerland (September 2016)
In HIV Treatment ALERTS!, from The Center for AIDS Information & Advocacy
On TheBodyPRO.com
- Acquired HIV Antiretroviral Resistance Is a 'Well-Controlled Relic' in Switzerland (August 30, 2016)
From TheBodyPRO
 Transmitted Drug Resistance: The Other Side to the PrEP Failure Case We're Not Talking About (May 2, 2016)
In The 23rd Conference on Retroviruses and Opportunistic Infections, from BETA
On TheBodyPRO.com
 HIV Drug Resistance Study Highlights Need for Viral Load Tests, Affordable Second-Line Treatments (November 18, 2015)
From Science Speaks
On TheBodyPRO.com
VIEW ALL ARTICLES
Resistance Risk
 This Week in HIV Research: Additional Nuance on Pregnancy and Antiretrovirals (March 28, 2019)
From TheBodyPRO
- This Week in HIV Research: Exorcizing Our PrEP Demons (March 21, 2019)
From TheBodyPRO
- Two Generations Explore HIV Drug Resistance in Trans Women, MSM (March 20, 2019)
From TheBodyPRO
 No Increased Resistance With Once-Daily Dosing of Abacavir and 3TC Than Twice-Daily Dosing in the ARROW Trial (July 31, 2016)
In The 21st International AIDS Conference (AIDS 2016), from HIV i-Base
On TheBodyPRO.com
 Study: Protease Inhibitor Monotherapy Does Not Limit Future Treatment Options (November 24, 2015)
From BETA
On TheBodyPRO.com
 Taking PrEP Does Not Increase Drug Resistance Risk (May 30, 2014)
From TheBodyPRO
- Some Children With HIV Grow Resistant to Drugs, Says Study (April 25, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from CDC National Prevention Information Network
On TheBodyPRO.com
- IRIN/PlusNews Examines Threat of HIV Drug-Resistance in Africa (September 13, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
On TheBodyPRO.com
- Protease Inhibitor to Raltegravir Switch Maintains Viral Suppression, but NRTI Resistance Lowers Efficacy (July 22, 2010)
From aidsmap.com
On TheBodyPRO.com
- Researchers Develop Questions to Determine Risk of HIV/AIDS Drug Resistance (May 19, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
On TheBodyPRO.com
VIEW ALL ARTICLES
Research on Drug Resistance: 1996-1998
- Highlights From the Resistance Workshop (August/September 1998)
A report from the 12th World AIDS Conference.
In TAGline, from Treatment Action Group
- Mechanisms of Antiretroviral Therapy Failure: Resistance (May 1, 1998)
In The 8th Clinical Care Options for HIV Symposium, from TheBodyPRO
- Emergence of HIV-1 Resistance in Seminal Plasma of Men on Antiretroviral Therapy (February 4, 1998)
In The 5th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO
- First Test for HIV Resistance to Nucleoside Analogs Is Available (December 1997)
In HIV Newsline, from San Francisco General Hospital
- Clinical Implications of Resistance to Antiretroviral Drugs (November 21, 1997)
From U.S. National Institute of Allergy and Infectious Diseases
- Update From the June 1997 International Workshop on HIV Drug Resistance, Treatment Strategies and Eradication (November 7, 1997)
From U.S. National Institute of Allergy and Infectious Diseases
- Is Resistance Always a Bad Thing? (June 1997)
In HIV Newsline, from San Francisco General Hospital
- Viral Resistance (report from the XIth International AIDS Conference) (Summer 1996)
In STEP Perspective, from Seattle Treatment Education Project
|
Advertisement
|
Email
Glossary
